- Clinical Trials
- January 2024
- 90 Pages
Global
From €2390EUR$2,500USD£2,054GBP
- Report
- May 2023
- 391 Pages
Global
From €4588EUR$4,799USD£3,943GBP
- Report
- November 2023
- 321 Pages
Global
From €4012EUR$4,197USD£3,448GBP
- Report
- May 2024
- 420 Pages
Global
From €3155EUR$3,300USD£2,711GBP
- Report
- December 2023
- 220 Pages
Global
From €3155EUR$3,300USD£2,711GBP
- Report
- August 2023
- 120 Pages
Global
From €2294EUR$2,400USD£1,972GBP
- Report
- March 2024
- 190 Pages
Global
From €3226EUR$3,374USD£2,772GBP
€3584EUR$3,749USD£3,080GBP
- Report
- March 2024
- 189 Pages
Global
From €3226EUR$3,374USD£2,772GBP
€3584EUR$3,749USD£3,080GBP
- Report
- February 2024
- 175 Pages
Global
From €4780EUR$5,000USD£4,108GBP
- Report
- February 2024
- 175 Pages
Global
From €4780EUR$5,000USD£4,108GBP
- Report
- February 2024
- 175 Pages
Global
From €4780EUR$5,000USD£4,108GBP
- Report
- February 2024
- 250 Pages
Global
From €4780EUR$5,000USD£4,108GBP
- Report
- January 2024
- 200 Pages
Global
From €4780EUR$5,000USD£4,108GBP
- Report
- January 2024
- 200 Pages
Global
From €4780EUR$5,000USD£4,108GBP
- Report
- January 2024
- 200 Pages
Global
From €4780EUR$5,000USD£4,108GBP
- Report
- January 2024
- 200 Pages
Global
From €4780EUR$5,000USD£4,108GBP
- Report
- January 2024
- 145 Pages
Global
From €3728EUR$3,899USD£3,203GBP
- Report
- May 2024
- 194 Pages
Global
From €4732EUR$4,950USD£4,067GBP
- Report
- November 2023
- 182 Pages
Global
From €4684EUR$4,900USD£4,026GBP
- Report
- November 2023
- 180 Pages
Global
From €4684EUR$4,900USD£4,026GBP
Programmed Cell Death Protein (PDP) is a type of protein that plays a role in the regulation of cell death in the body. It is a key component of the body's natural defense against cancer, as it helps to prevent the growth and spread of cancerous cells. In oncology drugs, PDP is used to target and destroy cancer cells, while leaving healthy cells unharmed. PDP is also used to reduce the side effects of chemotherapy and radiation therapy, as well as to reduce the risk of recurrence of cancer. PDP is also used to reduce the risk of metastasis, or the spread of cancer to other parts of the body.
PDP is a rapidly growing market, with many companies developing and marketing PDP-based drugs. Some of these companies include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. Show Less Read more